Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
2.
Qatar Medical Journal. 2007; 16 (2): 68-69
Dans Anglais | IMEMR | ID: emr-100455

Résumé

Lipid-lowering agents such as HMG-CoA reductase inhibitors [also known as statin drugs] are generally well tolerated. But a recognized side effect still can happen, We report a case of 47-year-old Iraqi male patient previously known hypothyroid, was not on replacement therapy, as he did not appear after his thyroid functions was checked came in with severe body pain for 10 months got worse in the last three months, started on lipostat [ten months ago] found to have myopathy as evident by high CPK which improved gradually clinically and biochemical after stopping lipostat


Sujets)
Humains , Mâle , Pravastatine , Maladies musculaires/étiologie , Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase , Hypolipémiants , Creatine kinase , Maladies musculaires/induit chimiquement
SÉLECTION CITATIONS
Détails de la recherche